Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Inflammation targets

For use in a small unit drop bomb designed to set fire to very inflammable targets, we developed a successful mixture con.sisting of tlie following ingredients ... [Pg.248]

In-house genomics anaiysis of the NF-kB signaling pathway characterized Proviral Integration Site in Murine Leukemia Virus 2 (Pim-2) as a potential inflammation target. Subsequent screening of our compound collection identified a series of cinnamic acids as potent and selective Pim-2 inhibitors. [Pg.186]

The anthrax toxin is a tripartite toxin and consists ofthe binding component protective antigen (PA), the lethal factor (LF), which is a metalloprotease, and the edema factor (EF), which is a calmodulin-dependent adenylyl-cyclase. Both enzyme components are translocated via PA into target cells. PA is activated by furin-induced cleavage and forms heptamers, which are similar to the binding components of C2 toxin and iota toxin. In the low pH compartment of endosomes, the heptamers form pores to allow translocation of LF and EF. LF cleaves six of the seven MEKs (MAPK-kinases) thereby inhibiting these enzymes. The functional consequence is the blockade of the MAPK pathways that control cell proliferation, differentiation, inflammation, stress response, and survival. Whether this is the reason for the LT-induced cell death of macrophages is not clear [1]. [Pg.247]

Catania A, Gatti S, Colombo G et al (2004) Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacol Rev 56 1—29... [Pg.757]

CD C14 C14.001 Caspase-1 Potential drug target for down-regulation of the inflammatory mediator, interleukin 1beta, which could ameliorate inflammation and endotoxic shock... [Pg.878]

MA M1 M01.004 Leukotriene A4 hydrolase Drug target to control inflammation... [Pg.879]

These disorders are all acquired conditions with no evidence of an hereditary basis. Most of them involve inflammation of the skeletal muscle itself (myositis) (Figure 17), though this may sometimes occur because of initial targeting of the muscle vasculature or connective tissue. Many instances of myositis are classed as idiopathic disorders, in that the precise mechanisms of muscle degeneration are not known, but is widely accepted that these syndromes are associated with abnormal function of the immune system. The syndromes of polymyositis (PM) and derma-... [Pg.323]

The histopathological features of PM may be radically different from those of JDM and ADM. There is little, if any, evidence of involvement of the micro vasculature and the muscle necrosis which occurs appears to be the direct result of targeting of individual muscle fibers. In the dermatomyositis syndromes, antibody-dependent humoral mechanisms are predominant and B-lymphocytes are seen to be the most abundant cell type in almost all JDM cases and a substantial proportion of ADM cases. In contrast, most muscle biopsies from PM patients show evidence of inflammation in which TS (cytotoxic) lymphocytes predominate (Figure 20). Moreover, the distribution of inflammatory cell infiltrates tends to be different. Instead of the mainly perifascicular location of lymphocytes in JDM/ADM, there... [Pg.329]

The pilosebaceous follicles are the target sites for acne. The pathophysiology of acne centers on interplay of follicular hyperkeratinization, increased sebum production, action of Propi-onibacterium acnes (P. acnes) within the follicle, and production of inflammation (Table 11.1). [Pg.113]

Polosa R, Holgate ST Adenosine receptors as promising therapeutic targets for drug development in chronic airway inflammation. Curr Drug Targets... [Pg.66]


See other pages where Inflammation targets is mentioned: [Pg.243]    [Pg.450]    [Pg.135]    [Pg.143]    [Pg.615]    [Pg.243]    [Pg.450]    [Pg.135]    [Pg.143]    [Pg.615]    [Pg.50]    [Pg.380]    [Pg.445]    [Pg.74]    [Pg.190]    [Pg.41]    [Pg.109]    [Pg.229]    [Pg.329]    [Pg.353]    [Pg.539]    [Pg.591]    [Pg.630]    [Pg.641]    [Pg.647]    [Pg.887]    [Pg.917]    [Pg.939]    [Pg.953]    [Pg.968]    [Pg.1009]    [Pg.1022]    [Pg.1105]    [Pg.1124]    [Pg.1209]    [Pg.1210]    [Pg.1229]    [Pg.1250]    [Pg.979]    [Pg.138]    [Pg.194]    [Pg.33]    [Pg.62]   
See also in sourсe #XX -- [ Pg.450 , Pg.451 ]




SEARCH



Inflammation molecular therapeutic targets

© 2024 chempedia.info